Guide to Targeted Therapies (Record no. 29045)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01395nam a22002537a 4500 |
001 - CONTROL NUMBER | |
control field | 20241004094921.0 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | 20241004094921.0 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20241004095418.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 241004b |||||||| |||| 00| 0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 978-3-319-03058-6 |
International Standard Book Number | 978-3-319-03059-3 |
040 ## - CATALOGING SOURCE | |
Transcribing agency | ddc |
041 ## - LANGUAGE CODE | |
Language code of text/sound track or separate title | English |
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Classification number | 616.994 CAP |
100 ## - MAIN ENTRY--PERSONAL NAME | |
Fuller form of name | Federico Cappuzzo |
245 ## - TITLE STATEMENT | |
Title | Guide to Targeted Therapies |
Remainder of title | EGFR Mutations in NSCLC. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Place of publication, distribution, etc. | London | |
Name of publisher, distributor, etc. | Springer International Publishing Switzerland | |
Date of publication, distribution, etc. | 2014 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 75 Pages |
Extent | Includes References |
520 ## - SUMMARY, ETC. | |
Summary, etc. | <br/>Guide to Targeted Therapies: EGFR Mutations in NSCLC is a speedy and up-to-date review, which discusses EGFR mutations, testing methods and technology, current and emerging therapies, and resources that clinicians can provide to their patients. Busy healthcare professionals who want a quick review of EGFR gene mutations as well as a summary of current therapies will benefit from this succinct guide. |
600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME | |
General subdivision | Medical / General, Medical / Oncology / General, Medical / Pharmacology, Medical / Pulmonary & Thoracic Medicine, Medical sciences, Oncology, Respiratory organs—Diseases, Therapeutics, Epidermal growth factor, Lungs -- Cancer -- Treatment, Medicine, Medicine and Public Health, Pneumology. |
856 ## - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="DOI 10.1007/978-3-319-03059-3 ">DOI 10.1007/978-3-319-03059-3 </a> |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Source of classification or shelving scheme | ddc |
Koha item type | E-BOOKS |
Suppress in OPAC |
Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Date acquired | Total checkouts | Full call number | Barcode | Date last seen | Uniform resource identifier | Price effective from | Koha item type |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | 10/04/2024 | 616.994 CAP | 20241004094921.0 | 10/04/2024 | DOI 10.1007/978-3-319-03059-3 | 10/04/2024 | E-BOOKS |